TI15
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: TI15 is an advanced dual-action somatotropic formulation combining 10mg of Tesamorelin (trans-3-hexenoyl GHRH) and 5mg of Ipamorelin (selective ghrelin receptor agonist) in a single 15mg lyophilized research standard.
How it works: Tesamorelin acts as the most potent clinical GHRH analogue approved for visceral adipose reduction, stimulating pituitary adenylate cyclase and cAMP. Ipamorelin selectively engages the pituitary GHS-R1a receptor, stimulating calcium influx and amplifying the growth hormone pulse amplitude while suppressing somatostatin. Together, they generate maximal natural pulsatile GH elevation and sustained lipolysis without elevating appetite, cortisol, or prolactin.
Why researchers study it: Studied for visceral deep belly fat reduction, liver fat mobilization, cardiovascular metabolic parameters, lean body mass preservation, and restorative deep sleep.




